Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer
Gross, Matt I, Demo, Susan D, Dennison, Jennifer B, Chen, Lijing, Chernov-Rogan, Tania, Goyal, Bindu, Janes, Julie R, Laidig, Guy J, Lewis, Evan R, Li, Jim, Mackinnon, Andrew L, Parlati, Francesco, Rodriguez, Mirna L M, Shwonek, Peter J, Sjogren, Eric B, Stanton, Timothy F, Wang, Taotao, Yang, Jinfu, Zhao, Frances, Bennett, Mark K
Published in Molecular cancer therapeutics (01.04.2014)
Published in Molecular cancer therapeutics (01.04.2014)
Get full text
Journal Article
The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma
Emberley, Ethan, Pan, Alison, Chen, Jason, Dang, Rosalyn, Gross, Matt, Huang, Tony, Li, Weiqun, MacKinnon, Andrew, Singh, Devansh, Sotirovska, Natalija, Steggerda, Susanne M, Wang, Tracy, Parlati, Francesco
Published in PloS one (03.11.2021)
Published in PloS one (03.11.2021)
Get full text
Journal Article
Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast
Cho, Yoonsang, Crichlow, Gregg V., Vermeire, Jon J., Leng, Lin, Du, Xin, Hodsdon, Michael E., Bucala, Richard, Cappello, Michael, Gross, Matt, Gaeta, Federico, Johnson, Kirk, Lolis, Elias J., Petsko, Gregory A.
Published in Proceedings of the National Academy of Sciences - PNAS (22.06.2010)
Published in Proceedings of the National Academy of Sciences - PNAS (22.06.2010)
Get full text
Journal Article
Abstract 2329: Glutaminase inhibition with CB-839 enhances anti-tumor activity of PD-1 and PD-L1 antibodies by overcoming a metabolic checkpoint blocking T cell activation
Gross, Matt, Chen, Jason, Englert, Judd, Janes, Julie, Leone, Robert, MacKinnon, Andy, Parlati, Francesco, Rodriquez, Mirna, Shwonek, Peter, Powell, Jonathan
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Get full text
Journal Article
Metabolomic, Proteomic and Genomic Profiling Identifies Biomarakers of Sensitivity to Glutaminase Inhibitor CB-839 in Multiple Myeloma
MacKinnon, Andrew L, Bennett, Mark, Gross, Matt, Janes, Julie, Li, Weiqin, Rodriquez, Mirna, Wang, Tracy, Zhang, Winter, Parlati, Francesco
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma
Ethan Emberley, Alison Pan, Jason Chen, Rosalyn Dang, Matt Gross, Tony Huang, Weiqun Li, Andrew MacKinnon, Devansh Singh, Natalija Sotirovska, Susanne M Steggerda, Tracy Wang, Francesco Parlati
Published in PloS one (01.01.2021)
Published in PloS one (01.01.2021)
Get full text
Journal Article
Antitumor Activity Of The Glutaminase Inhibitor CB-839 In Hematological Malignances
Parlati, Francesco, Bromley-Dulfano, Shoshana, Demo, Susan, Janes, Julie, Gross, Matt, Lewis, Evan, MacKinnon, Andy, Rodriguez, Mirna, Yang, Jinfu, Zhao, Frances, Bennett, Mark
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
AV411 (Ibudilast) and AV1013 are non-competitive inhibitors of macrophage migration inhibitory factor: a novel induced-fit allosteric inhibition mechanism (133.11)
Cho, Yoonsang, Crichlow, Gregg, Vermeire, Jon, Leng, Lin, Du, Xin, Hodsdon, Michael, Bucala, Richard, Cappello, Michael, Gross, Matt, Gaeta, Federico, Johnson, Kirk, Lolis, Elias
Published in The Journal of immunology (1950) (01.04.2010)
Published in The Journal of immunology (1950) (01.04.2010)
Get full text
Journal Article
METHOD, SYSTEM, AND APPARATUS FOR DETERMINING AND PROVISIONING LOCATION INFORMATION OF WIRELESS DEVICES
Gross, Matt, Korhonen, Antti, Horne, Jonathan, Duan, Chunjie, Ye, Zhenzhen
Year of Publication 28.07.2021
Get full text
Year of Publication 28.07.2021
Patent